165 related articles for article (PubMed ID: 25733318)
1. Can thromboembolic risk be associated with erectile dysfunction in atrial fibrillation patients?
Szymański FM; Filipiak KJ; Płatek AE; Kotkowski M; Opolski G
Cardiol J; 2015; 22(4):446-52. PubMed ID: 25733318
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolic risk evaluation in patients with atrial fibrillation using a modified CHADS(2) scoring system.
Cha MJ; Oh GC; Hahn S; Choi EK; Oh S
J Cardiovasc Electrophysiol; 2012 Feb; 23(2):155-62. PubMed ID: 21955174
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Erectile Dysfunction in Atrial Fibrillation Patients: A Cross-Sectional, Epidemiological Study.
Platek AE; Hrynkiewicz-Szymanska A; Kotkowski M; Szymanski FM; Syska-Suminska J; Puchalski B; Filipiak KJ
Pacing Clin Electrophysiol; 2016 Jan; 39(1):28-35. PubMed ID: 26412411
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation.
Abu-Assi E; Otero-Raviña F; Allut Vidal G; Coutado Méndez A; Vaamonde Mosquera L; Sánchez Loureiro M; Caneda Villar MC; Fernández Villaverde JM; Maestro Saavedra FJ; González-Juanatey JR;
Int J Cardiol; 2013 Jun; 166(1):205-9. PubMed ID: 22104995
[TBL] [Abstract][Full Text] [Related]
5. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
Botto GL; Padeletti L; Santini M; Capucci A; Gulizia M; Zolezzi F; Favale S; Molon G; Ricci R; Biffi M; Russo G; Vimercati M; Corbucci G; Boriani G
J Cardiovasc Electrophysiol; 2009 Mar; 20(3):241-8. PubMed ID: 19175849
[TBL] [Abstract][Full Text] [Related]
6. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.
Tsai CT; Chang SH; Chang SN; Hwang JJ; Wu CK; Wang YC; Tseng CD; Yeh HM; Lai LP; Chiang FT; Lin JL
Heart Rhythm; 2014 Mar; 11(3):352-7. PubMed ID: 24252289
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation is associated with increased risk of erectile dysfunction: A nationwide population-based cohort study.
Lin WY; Lin CS; Lin CL; Cheng SM; Lin WS; Kao CH
Int J Cardiol; 2015; 190():106-10. PubMed ID: 25918058
[TBL] [Abstract][Full Text] [Related]
9. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
[TBL] [Abstract][Full Text] [Related]
10. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.
Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J
Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861
[TBL] [Abstract][Full Text] [Related]
11. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
Chao TF; Lin YJ; Tsao HM; Tsai CF; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Ambrose K; Wu TJ; Chen SA
J Am Coll Cardiol; 2011 Nov; 58(23):2380-5. PubMed ID: 22115643
[TBL] [Abstract][Full Text] [Related]
12. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
13. Management of patients with valvular and non-valvular atrial fibrillation in Poland: Results from Reference Cardiology University Center.
Łopatowska P; Tomaszuk-Kazberuk A; Młodawska E; Bachórzewska-Gajewska H; Małyszko J; Dobrzycki S; Musiał WJ
Cardiol J; 2015; 22(3):296-305. PubMed ID: 25428729
[TBL] [Abstract][Full Text] [Related]
14. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
15. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and characteristics of OSAFED syndrome in atrial fibrillation primary care patients.
Wolf J; Dereziński T; Szyndler A; Narkiewicz K
Kardiol Pol; 2017; 75(5):432-438. PubMed ID: 28181212
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation in outpatients with stable coronary artery disease: results from the multicenter RECENT study.
Zielonka A; Tkaczyszyn M; Mende M; Nowak W; Rekucki K; Soczomski P; Zieliński M; Pociupany R; Wilkins A; Banasiak W; Ponikowski P; Jankowska EA
Pol Arch Med Wewn; 2015; 125(3):162-71. PubMed ID: 25644126
[TBL] [Abstract][Full Text] [Related]
18. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY
J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209
[TBL] [Abstract][Full Text] [Related]
19. The relationship between erectile dysfunction and paroxysmal lone atrial fibrillation.
Yılmaz S; Kuyumcu MS; Akboga MK; Sen F; Balcı KG; Balcı MM; Özeke Ö; Aras D; Aydoğdu S
J Interv Card Electrophysiol; 2016 Sep; 46(3):245-51. PubMed ID: 26883851
[TBL] [Abstract][Full Text] [Related]
20. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
